These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

388 related items for PubMed ID: 21788912

  • 1. Horizontal distribution of the fecal microbiota in adolescents with inflammatory bowel disease.
    Gosiewski T, Strus M, Fyderek K, Kowalska-Duplaga K, Wedrychowicz A, Jedynak-Wasowicz U, Sladek M, Pieczarkowski S, Adamski P, Heczko PB.
    J Pediatr Gastroenterol Nutr; 2012 Jan; 54(1):20-7. PubMed ID: 21788912
    [Abstract] [Full Text] [Related]

  • 2. Fungi and inflammatory bowel diseases: Alterations of composition and diversity.
    Ott SJ, Kühbacher T, Musfeldt M, Rosenstiel P, Hellmig S, Rehman A, Drews O, Weichert W, Timmis KN, Schreiber S.
    Scand J Gastroenterol; 2008 Jan; 43(7):831-41. PubMed ID: 18584522
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Specificities of the fecal microbiota in inflammatory bowel disease.
    Sokol H, Seksik P, Rigottier-Gois L, Lay C, Lepage P, Podglajen I, Marteau P, Doré J.
    Inflamm Bowel Dis; 2006 Feb; 12(2):106-11. PubMed ID: 16432374
    [Abstract] [Full Text] [Related]

  • 5. Rectal bleeding in infancy: clinical, allergological, and microbiological examination.
    Arvola T, Ruuska T, Keränen J, Hyöty H, Salminen S, Isolauri E.
    Pediatrics; 2006 Apr; 117(4):e760-8. PubMed ID: 16585287
    [Abstract] [Full Text] [Related]

  • 6. Elevated human beta-defensin-2 levels indicate an activation of the innate immune system in patients with irritable bowel syndrome.
    Langhorst J, Junge A, Rueffer A, Wehkamp J, Foell D, Michalsen A, Musial F, Dobos GJ.
    Am J Gastroenterol; 2009 Feb; 104(2):404-10. PubMed ID: 19174795
    [Abstract] [Full Text] [Related]

  • 7. Spatial organization and composition of the mucosal flora in patients with inflammatory bowel disease.
    Swidsinski A, Weber J, Loening-Baucke V, Hale LP, Lochs H.
    J Clin Microbiol; 2005 Jul; 43(7):3380-9. PubMed ID: 16000463
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Ex vivo response to mucosal bacteria and muramyl dipeptide in inflammatory bowel disease.
    Loganes C, Valencic E, Pin A, Marini E, Martelossi S, Naviglio S, De Leo L, Not T, Monasta L, Tommasini A, Marcuzzi A.
    World J Gastroenterol; 2016 Nov 28; 22(44):9734-9743. PubMed ID: 27956797
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Correlations between colonic crypt mucin chemotype, inflammatory grade and Desulfovibrio species in ulcerative colitis.
    Lennon G, Balfe Á, Bambury N, Lavelle A, Maguire A, Docherty NG, Coffey JC, Winter DC, Sheahan K, O'Connell PR.
    Colorectal Dis; 2014 May 28; 16(5):O161-9. PubMed ID: 24345279
    [Abstract] [Full Text] [Related]

  • 12. Terminal restriction fragment length polymorphism analysis of the gut microbiota profiles of pediatric patients with inflammatory bowel disease.
    Aomatsu T, Imaeda H, Fujimoto T, Takahashi K, Yoden A, Tamai H, Fujiyama Y, Andoh A.
    Digestion; 2012 May 28; 86(2):129-35. PubMed ID: 22846404
    [Abstract] [Full Text] [Related]

  • 13. Bacterial L-form isolation from inflammatory bowel disease patients.
    Belsheim MR, Darwish RZ, Watson WC, Schieven B.
    Gastroenterology; 1983 Aug 28; 85(2):364-9. PubMed ID: 6134652
    [Abstract] [Full Text] [Related]

  • 14. Microbiota in pediatric inflammatory bowel disease.
    Schwiertz A, Jacobi M, Frick JS, Richter M, Rusch K, Köhler H.
    J Pediatr; 2010 Aug 28; 157(2):240-244.e1. PubMed ID: 20400104
    [Abstract] [Full Text] [Related]

  • 15. [Functional biostructure of colonic microbiota (central fermenting area, germinal stock area and separating mucus layer) in healthy subjects and patients with diarrhea treated with Saccharomyces boulardii].
    Swidsinski A, Loening-Baucke V, Kirsch S, Doerffel Y.
    Gastroenterol Clin Biol; 2010 Sep 28; 34 Suppl 1():S79-92. PubMed ID: 20889010
    [Abstract] [Full Text] [Related]

  • 16. Gram-negative bacteria account for main differences between faecal microbiota from patients with ulcerative colitis and healthy controls.
    Vigsnæs LK, Brynskov J, Steenholdt C, Wilcks A, Licht TR.
    Benef Microbes; 2012 Dec 01; 3(4):287-97. PubMed ID: 22968374
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Regional distribution and alterations of lectin binding to colorectal mucin in mucosal biopsies from controls and subjects with inflammatory bowel diseases.
    Jacobs LR, Huber PW.
    J Clin Invest; 1985 Jan 01; 75(1):112-8. PubMed ID: 3965499
    [Abstract] [Full Text] [Related]

  • 20. In vitro batch cultures of gut microbiota from healthy and ulcerative colitis (UC) subjects suggest that sulphate-reducing bacteria levels are raised in UC and by a protein-rich diet.
    Khalil NA, Walton GE, Gibson GR, Tuohy KM, Andrews SC.
    Int J Food Sci Nutr; 2014 Feb 01; 65(1):79-88. PubMed ID: 23941288
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.